Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07602530
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical PracticeAstellas Pharma Europe Ltd.Recruiting
NCT07602530Recruiting
—
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezoline...Astellas Pharma Europe Lt...
NCT07602712
Using Illusions to Boost Social CognitionHôpital le VinatierNot Yet RecruitingNot Applicable
NCT07602712Not Yet Recruiting
Not Applicable
Using Illusions to Boost Social CognitionHôpital le Vinatier
NCT07601737
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell CarcinomaShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruitingPhase 2
NCT07601737Recruiting
Phase 2
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of L...Shanghai General Hospital...
NCT07603050
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in Patients With Type III Gaucher's DiseaseShanghai Vitalgen BioPharma Co., Ltd.Not Yet RecruitingPhase 1
NCT07603050Not Yet Recruiting
Phase 1
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in P...Shanghai Vitalgen BioPhar...
NCT07602231
Effectiveness of Enhanced Recovery After Surgery (ERAS) Protocols for Arthroscopic Anterior Cruciate Ligament Reconstruction in an Ambulatory Surgery SettingUniversity Medical Center Ho Chi Minh City (UMC)Not Yet RecruitingNot Applicable
NCT07602231Not Yet Recruiting
Not Applicable
Effectiveness of Enhanced Recovery After Surgery (ERAS) Protocols for Arthroscop...University Medical Center...
NCT07604129
Transcranial Sonography and Machine Learning for Schizophrenia IdentificationTaizhou Second People's HospitalNot Yet Recruiting
NCT07604129Not Yet Recruiting
—
Transcranial Sonography and Machine Learning for Schizophrenia IdentificationTaizhou Second People's H...
NCT07604909
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant ChemotherapyFudan UniversityRecruitingPhase 2
NCT07604909Recruiting
Phase 2
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Thera...Fudan University
NCT07604415
Active Versus Passive Anal Sphincter Training in Patients With Fecal IncontinenceComenius UniversityRecruitingNot Applicable
NCT07604415Recruiting
Not Applicable
Active Versus Passive Anal Sphincter Training in Patients With Fecal Incontinenc...Comenius University
NCT07600853
Development and Validation of an E-learning Module on Systemic Anticancer Therapy and Its Effectiveness on the Knowledge Attitude and Practice of Nurses in Administering Systemic Anticancer Agents at a Specialized Cancer Centres in Oman.Sultan Qaboos Comprehensive Cancer CenterNot Yet RecruitingNot Applicable
NCT07600853Not Yet Recruiting
Not Applicable
Development and Validation of an E-learning Module on Systemic Anticancer Therap...Sultan Qaboos Comprehensi...
NCT07603765
Minimally Invasive Hemodynamic Monitoring in Cardiac AblationIstanbul University - CerrahpasaRecruiting
NCT07603765Recruiting
—
Minimally Invasive Hemodynamic Monitoring in Cardiac AblationIstanbul University - Cer...
NCT07604610
Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian PopulationsNational Medical Research Center for Therapy and Preventive MedicineRecruiting
NCT07604610Recruiting
—
Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian PopulationsNational Medical Research...
NCT07603700
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary EmbolismNanjing First Hospital, Nanjing Medical UniversityNot Yet Recruiting
NCT07603700Not Yet Recruiting
—
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonar...Nanjing First Hospital, N...
NCT07603310
Influence of Lung Recruitment Potential on PEEP Titration Strategies in ARDS Patients.Hospital Dr. Franco Ravera ZuninoNot Yet RecruitingNot Applicable
NCT07603310Not Yet Recruiting
Not Applicable
Influence of Lung Recruitment Potential on PEEP Titration Strategies in ARDS Pat...Hospital Dr. Franco Raver...
NCT07603219
Nurse-Led Educational Intervention for Caregivers of ICU Patients (Nurses For Family - N4F)Medical University of GdanskNot Yet RecruitingNot Applicable
NCT07603219Not Yet Recruiting
Not Applicable
Nurse-Led Educational Intervention for Caregivers of ICU Patients (Nurses For Fa...Medical University of Gda...
NCT07604142
Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant PlacementTanta UniversityEnrolling By InvitationNot Applicable
NCT07604142Enrolling By Invitation
Not Applicable
Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant...Tanta University
NCT07603193
Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib CreamICON Clinical ResearchEnrolling By Invitation
NCT07603193Enrolling By Invitation
—
Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment W...ICON Clinical Research
NCT07604454
Muscle Energy Technique Combined With Mulligan Technique in Tennis ElbowUniversity of LahoreCompletedNot Applicable
NCT07604454Completed
Not Applicable
Muscle Energy Technique Combined With Mulligan Technique in Tennis ElbowUniversity of Lahore
NCT07600866
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan CohortNucleo Research, Inc.Not Yet Recruiting
NCT07600866Not Yet Recruiting
—
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Sc...Nucleo Research, Inc.
NCT07600957
Polarized Light Therapy for Radiation Dermatitis in Breast CancerBeni-Suef UniversityNot Yet RecruitingNot Applicable
NCT07600957Not Yet Recruiting
Not Applicable
Polarized Light Therapy for Radiation Dermatitis in Breast CancerBeni-Suef University
Result Breakdown
Not yet recruiting11 (55%)
Recruiting6 (30%)
Enrolling by invitation2 (10%)
Completed1 (5%)
not_applicable10 (50%)
Not Specified7 (35%)
Phase 22 (10%)
Phase 11 (5%)